SUCNR1 and atherosclerosis: Taking into account the current knowledge that GPR91 may play different cellular-specific roles in the spectrum of cardiometabolic diseases, future studies targeting this receptor, through ablation or overexpression, specifically in metabolic, vascular or immune cells, as well as the evaluation of disease at different stages, will be needed to provide definitive proof of the involvement of GPR91 signalling in the pathophysiological process of atherosclerosis.